B-JECT 200 mg — Muscule Pharm

B-JECT 200 mg Muscule Pharm

Muscule Pharm

€50,00

In Stock (100 available)

B-JECT 200 mg Muscule Pharm (200 mg) — Backed by Muscule Pharm’s commitment to quality, a highly versatile injectable steroid that produces lean, quality muscle gains wi…

100 in stock

5+ −10%

10+ −15% Best price

Third-Party Lab Report HPLC verified

CoA available on request — email support@vitalquests.org with the batch code from your vial.

HPLC TestedBatch report available

No Labels on BoxPlain brown parcel

Pay the CourierCash on delivery only

Ships TodayOrder before 14:00

€85+ = free shipping

EU warehouse — no customs, no delays

Tracked via DHL / DPD / InPost

Description

B-JECT 200 mg Muscule Pharm — Backed by a rigorous commitment to quality, a highly versatile injectable steroid that produces lean, quality muscle gains without the excessive water retention associated with many mass builders. Originally developed for veterinary use, Boldenone has become a staple in bodybuilding for its unique combination of steady lean mass accrual, appetite enhancement, and dramatic vascularity improvements. Its exceptionally long half-life of 14 days provides ultra-stable blood levels. This formulation is dosed at 200 mg per unit.

Key Benefits

Multi-ester blend — acute kick + long-tail coverage from one injection
Classic Sustanon / Omnadren formulation (prop + phenyl + iso + deca)
Twice-weekly pinning schedule covers all four ester kinetics
Behaves functionally like testosterone enanthate for cycle planning
Popular pharma-grade option where single-ester vials aren’t available
Each unit dosed at 200 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: 250–750 mg/week; TRT 100–200 mg/week. Split across at least 2 injections (Mon/Thu). Shorter esters in the blend push injection frequency — once-weekly produces noticeable troughs.

How It Works

Mixture of 4 testosterone esters: propionate (fast), phenylpropionate (short-medium), isocaproate (medium), decanoate (long). At the AR the active hormone is identical across esters; the blend provides staggered release kinetics for smoother coverage.

Pharmacokinetics

Composite release: propionate peaks in ~24 h, phenylpropionate ~2 days, isocaproate ~3–4 days, decanoate ~7–10 days. Net effect similar to enanthate but with a gentler peak. Steady-state in 4 weeks. PCT starts 2 weeks after last injection.

Potential Side Effects

Standard testosterone side-effect profile. Propionate fraction can cause PIP; some users prefer pure enanthate for tolerability. AI dose by bloodwork — hematocrit and E2 at week 6.

Cycle & Stacking Guide

Cycle base identical to enanthate: 12–16 weeks for mass/recomp, paired with secondary compounds per goal. Twice-weekly pinning mandatory. PCT (Clomid + Nolva) 14 days after last pin.

Manufacturer Notes

Muscule Pharm produces standardised AAS oils with labelled pre-filled concentrations. Each SKU’s letter prefix denotes the ester family (T=testosterone, P=propionate, W=winstrol, etc.).

Storage & Handling

Store at recommended temperature (15–25°C; peptides and HGH at 2–8°C after reconstitution). Protect from light and moisture. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “B-JECT 200 mg Muscule Pharm”

2D structural representation · PubChem CID 197042 ↗

Chemical Identity
#	CAS Registry Number	`13103-34-9`
Σ	IUPAC Name	[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] undec-10-enoate
F	Molecular Formula	C₃₀H₄₄O₃
M	Molecular Weight	452.67 g/mol
⌬	SMILES	`C=CCCCCCCCCC(=O)O[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@H]3CC[C@]12C`
⊞	InChIKey	`WSVLPPMCNTCMFS-UHFFFAOYSA-N`
△	Melting Point	Oil (liquid at RT) °C
≋	Solubility	Insoluble in water; soluble in oils
t½	Biological Half-life	14 days (IM)
⊕	PubChem CID	197042 ↗

Pharmacological Profile
Anabolic Rating	100
Androgenic Rating	50
Aromatization	Low
Hepatotoxicity	None
Detection Time	5 months

Clinical Notes

Mechanism & protocol-relevant pharmacology, reviewed by editorial pharmacology lead

Dehydrotestosterone — testosterone analogue with an added 1,2-double bond. AR binding is measurable but lower than parent testosterone; the clinically interesting feature is upregulation of erythropoietin production, producing hematocrit drift steeper than any other injectable AAS. Bloodwork pattern: HCT climbs 6–8 percentage points over a 16-week run without compensatory caloric intake changes. Erythrocytosis is the rate-limiting variable, not androgen dose. Aromatisation is low (~half testosterone rate) but estradiol creep occurs on long cycles — AI requirement is patient-specific rather than protocol-wide. Undecylenate ester: 14-day half-life and predictable weekly dosing. Appetite stimulation is direct (hypothalamic NPY pathway) and begins within 2 weeks of protocol initiation.

Known trade names: Equipoise, Boldebal, Boldane

External references

Data sourced from published pharmacological literature and authoritative chemical databases (PubChem, DrugBank, ChEBI). Provided for identification and research reference only.

B-JECT 200 mg Muscule Pharm